| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 04/13/2006 | WO2006038989A1 Substituted arylamides |
| 04/13/2006 | WO2006038172A1 New piperidine antibiotics |
| 04/13/2006 | WO2006037761A1 New histone deacetylases inhibitors |
| 04/13/2006 | WO2006037279A1 Recording medium for three dimension operating memory |
| 04/13/2006 | WO2006028958A3 Pyridyl inhibitors of hedgehog signalling |
| 04/13/2006 | WO2006013550A3 Process for preparation of piperidine carboxylic acid |
| 04/13/2006 | US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders |
| 04/13/2006 | US20060079518 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 04/13/2006 | DE102004023635A1 Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate Heteroaryl-cyclohexyl-1,4-diamine derivatives |
| 04/13/2006 | CA2582356A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2582347A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2581057A1 New piperidine antibiotics |
| 04/12/2006 | EP1645552A1 Double-spiro organic compounds and electroluminescent devices |
| 04/12/2006 | EP1644373A1 Tricyclic delta opioid modulators |
| 04/12/2006 | EP1644370A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1644366A1 Mch antagonists for the treatment of obesity |
| 04/12/2006 | EP1644365A2 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 04/12/2006 | EP1644363A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 04/12/2006 | EP1644357A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2006 | EP1644353A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 04/12/2006 | EP1644339A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 04/12/2006 | EP1644337A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/12/2006 | EP1644335A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1644322A1 Aspartyl protease inhibitors |
| 04/12/2006 | EP1643988A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 04/12/2006 | EP1542988B1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same |
| 04/12/2006 | EP1358183B1 Cysteine protease inhibitors |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759112A Benzimidazole derivatives and their use for modulating the GABA- SB A /SB receptor complex |
| 04/12/2006 | CN1759108A Biphenyl derivatives |
| 04/12/2006 | CN1758915A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 04/12/2006 | CN1250542C 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 04/12/2006 | CN1250538C Conductive compound, electrode and sensor contain said conductive compound and method for detecting target molecule by using sad sensor |
| 04/12/2006 | CN1250533C Novel azoles having an insecticidal action |
| 04/12/2006 | CN1250531C Novel compounds |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026346 Anticancer agents |
| 04/11/2006 | US7026339 Inhibitors of HCV NS5B polymerase |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026323 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 04/11/2006 | CA2281702C (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/11/2006 | CA2181570C Metalloproteinase inhibitors |
| 04/06/2006 | WO2006037117A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | WO2006036994A2 Modulators of crth2, cox-2 and faah |
| 04/06/2006 | WO2006036527A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | WO2006036507A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036497A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036404A1 4-(substituted cycloalkylmethyl) imidazole-2-thones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cyloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 04/06/2006 | WO2006036024A1 Proton pump inhibitors |
| 04/06/2006 | WO2006036015A2 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 04/06/2006 | WO2006035303A1 Muscarinic receptor antagonists |
| 04/06/2006 | WO2006035068A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/06/2006 | WO2006035067A2 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | WO2006034833A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | WO2006034822A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/06/2006 | WO2006023460A3 COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 04/06/2006 | WO2005102335A3 Methods of treating sleep disorders |
| 04/06/2006 | US20060074245 Reacting a 5-( beta -ketoalkyl)-3-substituted-1,2,4-oxadiazoles compound with hydrazine |
| 04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 04/06/2006 | US20060074238 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074120 cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism |
| 04/06/2006 | US20060074119 Thiophene compounds |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074082 (Arylamidoaryl)cyanoguanidine compounds |
| 04/06/2006 | US20060074069 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders |
| 04/06/2006 | US20060074068 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 04/06/2006 | DE102004044829A1 5-Heterocyclylpyrimidine 5-Heterocyclylpyrimidine |
| 04/06/2006 | CA2582777A1 Proton pump inhibitors |
| 04/06/2006 | CA2582225A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | CA2581828A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581823A1 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581580A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 04/06/2006 | CA2581179A1 6-(pyridinyl)-4 pyrimidone derivatives as tau protein kinase 1 inhibitors |
| 04/06/2006 | CA2580838A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | CA2577467A1 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | CA2577185A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | CA2573976A1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/05/2006 | EP1641786A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 04/05/2006 | EP1641785A2 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhibitors |
| 04/05/2006 | EP1641762A2 Cck-1 receptor modulators |
| 04/05/2006 | EP1641752A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1086098B1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/05/2006 | CN1756746A 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249064C Tosylate and benzene sulfonate of pyrazolopy ridone compound |
| 04/05/2006 | CN1249057C Chromenylmethyl pyrimidinediamines as antibacterial agents |
| 04/05/2006 | CN1249052C Pyrazole derivatives as HIV reverse transcriptase inhibitors |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249050C Acrylate compounds and use |